Page last updated: 2024-08-24

3-iodobenzylguanidine and Mast-Cell Sarcoma

3-iodobenzylguanidine has been researched along with Mast-Cell Sarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beierwaltes, W; Froelich, J; Gonin, J; Macfarlane, D; Mangner, T; Shapiro, B; Wieland, D1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Mast-Cell Sarcoma

ArticleYear
Successful and unsuccessful approaches to imaging carcinoids: comparison of a radiolabelled tryptophan hydroxylase inhibitor with a tracer of biogenic amine uptake and storage, and a somatostatin analogue.
    European journal of nuclear medicine, 1996, Volume: 23, Issue:2

    Topics: 3-Iodobenzylguanidine; Adult; Animals; Carcinoid Tumor; Dogs; Enzyme Inhibitors; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Iodobenzenes; Mast-Cell Sarcoma; Mice; Middle Aged; Neoplasms, Experimental; Phenylalanine; Predictive Value of Tests; Radionuclide Imaging; Rats; Sensitivity and Specificity; Serotonin; Somatostatin; Tissue Distribution; Tryptophan Hydroxylase

1996